Antimicrobial Stewardship Program Using Plan-Do-Study-Act Cycles to Reduce Unjustified Antibiotic Prescribing in

Sasha E Dorzin1, Claudia Halaby1, Maria Lyn Quintos1

  • 1Department of Pharmacy (SED, GE), NYU Winthrop Hospital, Mineola, New York, Pediatric Pulmonary Medicine (CH), the Children's Medical Center, NYU Winthrop Hospital, Mineola, New York, Department of Quality and Patient Safety (MLQ), the Children's Medical Center, NYU Winthrop Hospital, Mineola, New York, Pediatric Infectious Diseases (AN), the Children's Medical Center, NYU Winthrop Hospital, Mineola, New York, Department of Pharmacy (GE), NYU Winthrop Hospital, Mineola, New York, and Department of Clinical Health Professions, St John's University College of Pharmacy and Health Sciences, Jamaica, New York.

Insights

An antimicrobial stewardship program (ASP) successfully reduced unjustified antibiotic use in children with asthma by 25%. This initiative lowered the rate of unnecessary antibiotic prescriptions to 5.9%, surpassing national guidelines.

Area of Science:

  • Pediatric pulmonology
  • Infectious diseases
  • Antimicrobial resistance

Background:

  • National asthma guidelines advise against antibiotics for exacerbations unless infection or comorbidities are present.
  • A prior study at the institution found 7.8% of antibiotics were unjustified in pediatric asthma admissions.
  • The American Academy of Pediatrics benchmark for unjustified antibiotic use is 6.6%.

Purpose of the Study:

  • To decrease unjustified antibiotic use by 25% in pediatric asthma patients.
  • To implement an antimicrobial stewardship program (ASP) targeting asthma exacerbations.
  • To align antibiotic prescribing with established national guidelines.

Main Methods:

  • A multidisciplinary team implemented interventions using Plan-Do-Study-Act cycles over a 5-month period (November 2015-March 2016).
  • Interventions included disseminating asthma guidelines, educating pediatric emergency department staff, and conducting a journal club on azithromycin's role.
  • The study included children aged 6 months to 17 years admitted for asthma exacerbations, excluding those with comorbidities.

Main Results:

  • The unjustified antibiotic prescribing rate decreased from 8.3% in Cycle 1 to 8.7% in Cycle 2, and ultimately to 0% in Cycle 3.
  • Across all cycles, 68 patients were evaluated, with a final unjustified antibiotic prescribing rate of 5.9%.
  • This represents a 25% reduction in unjustified antibiotic use, meeting the study's primary objective.

Conclusions:

  • The implemented antimicrobial stewardship program effectively reduced unjustified antibiotic use in pediatric asthma patients.
  • The study achieved a 5.9% unjustified antibiotic prescribing rate, which is below the American Academy of Pediatrics benchmark of 6.6%.
  • This demonstrates the success of targeted ASP interventions in optimizing antibiotic prescribing for pediatric asthma.
Abstract

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
60.3K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.1K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K